Protek-GFR Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Ca-4-methyl-2-oxo-valerate (α-ketoanalogue to leucine, Ca salt) 101 mg, Ca-3-methyl-2-oxo-butyrate (α-ketoanalogue to valine, Ca salt) 86 mg, Ca-2-oxo-3-phenylpropionate (α-ketoanalogue to phenylalanine, Ca salt) 68 mg, Ca-3-methyl-2-oxo-valerate (α-ketoanalogue to isoleucine, Ca salt) 67 mg, Ca-DL-2-hydroxy-4-(methylthio) butyrate (α-hydroxyanalogue to methionine, Ca salt) 59 mg, L-lysine acetate 105 mg, L-threonine 53 mg, L-histidine 38 mg, L-tyrosine 30 mg, L-tryptophan 23 mg

Indications/Uses

Prevention & therapy of damages due to faulty or deficient protein metabolism in chronic renal insufficiency in connection w/ limited protein in food of 40 g/day (for adults), ie, generally in patients w/ GFR <25 mL/min.

Click to view Protek-GFR detailed prescribing information

Dosage/Direction for Use

Adult 70 kg 4-8 tab tid.

Click to view Protek-GFR detailed prescribing information

Overdosage

View Protek-GFR overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Swallow whole. Do not chew/crush.

Contraindications

Hypercalcaemia, disturbed amino acid metabolism. Hereditary phenylketonuria; contains phenylalanine. No experience in pregnancy & ped.

Click to view Protek-GFR detailed prescribing information

Special Precautions

Regularly monitor serum Ca level. Ensure the sufficient supply of cal. No experience in pregnancy & lactation.

Click to view Protek-GFR detailed prescribing information

Use In Pregnancy & Lactation

Click to view Protek-GFR detailed prescribing information

Adverse Reactions

Hypercalcaemia.

Click to view Protek-GFR detailed prescribing information

Drug Interactions

May lead to pathological increases of serum Ca level or intensification w/ simultaneous administration of medicaments containing Ca (eg, acetolyte). Reduce possible administration of Al hydroxide due to improved uraemic symptoms under therapy. Reduction of serum phosphate might interfere w/ the absorption. Not to be taken w/ drugs that form sparingly soluble compd w/ Ca (eg, tetracyclines, ciprofloxacin & norfloxacin, Fe fluoride & estramustine-containing drugs). Increased susceptibility towards heart/cardiac-active glycosides & hence risk of arrhythmia w/ the raise of blood Ca conc.

Click to view Protek-GFR detailed prescribing information

Storage

View Protek-GFR storage conditions for details to ensure optimal shelf-life.

Description

View Protek-GFR description for details of the chemical structure and excipients (inactive components).

Action

View Protek-GFR mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Drugs Acting on the Genito-Urinary System

ATC Classification

V06DE - Amino acids/carbohydrates/minerals/vitamins, combinations ; Used as general nutrients.

Regulatory Classification

Presentation/Packing

Form

Protek-GFR FC tab

Packing/Price

100's (P19.95/film-coated tab)

Protek-GFR

Manufacturer:

GXI

Distributor:

Metro Drug